Hydroxy Compound Active Ingredients TRIZ Cases

A pharmaceutical composition incorporates an adrenergic receptor interacter within a polymeric matrix to facilitate drug permeation across biological membranes.

A polyherbal composition regulates insulin and hormonal levels to alleviate polycystic ovary syndrome symptoms.

Positively charged modified cyclodextrins shield organs from ischemia-reperfusion damage, extending preservation time while maintaining long-term viability.

A topical pharmaceutical composition merges cannabidiol, ashwagandha extracts, and dimethyl sulfoxide to deliver rapid pain relief.

Oral crude Dunaliella powder reduces PASI scores and toxicity risks associated with synthetic retinoids, improving patient quality of life.

Encapsulating curcumin and thymol in a polymer composite protects unstable bioactives from degradation while improving bioavailability.

Antibodies cross-link target cells with erythrocytes to form immunorosettes labeled by magnetic particles.

Adding terpenes before decarboxylation preserves volatile compounds lost during processing, improving therapeutic efficacy.

Heterologous enzymes convert beta-carotene to trans-retinyl acetate, eliminating energy-intensive chemical synthesis and complex purification steps.

Sucrose ester surfactants stabilize retinoid emulsions, preventing degradation while enabling zero-order release kinetics.

3,3-dimethyl-1-butanol inhibits trimethylamine production in the gut to lower cardiovascular disease risk.

Resveratrol-piperazine co-crystals improve bioavailability to address swine ileitis, overcoming low solubility limits of natural plant extracts.

A C′-CEO formulation combines carvacrol, curcumin, epigallocatechin-3-gallate, and oligomeric procyanidins to treat osteoarthritis.

A pharmaceutical composition blends reduced-dose synthetic active ingredients with cannabidiol isolate to amplify analgesic effects.

Bovine colostrum mediates oral vaccine uptake in children with environmental enteric dysfunction, overcoming impaired absorptive functions.

Compounds targeting MGST1 levels in cancer cells treat chemo-resistant tumors while reducing systemic toxicity.

Plant-derived capsule shells filter specific light wavelengths to protect compound danshen dripping pills from degradation caused by environmental stress.

A composition combining unsaturated higher alcohol with polyvalent alcohol increases transdermal absorption of acidic drugs.

A multi-cannabinoid and polysaccharide formulation reduces chemotherapy-induced nausea, pain, and neuropathy.

Combining preformed Vitamin A with non-digestible oligosaccharides in infant formula to enhance oral immune tolerance.

A composite active ingredient group comprising rhein, hesperetin, albiflorin, and magnolol regulates key metabolic pathways for constipation treatment.

Sugar alcohols bridge lipophilic cannabinoids and aqueous matrices, resolving mixture homogeneity issues while masking off-notes.

Beta-caryophyllene replaces synthetic solvents to extract bioactive compounds without leaving toxic residues or requiring complex purification steps.

Multiparticulate cannabinoid dosage uses enteric coating to bypass stomach release and target intestinal inflammation sites.

Pre-formed biofilms on biocompatible microspheres enhance colonization persistence, preventing necrotizing enterocolitis in neonates.

Replacing caffeine with apigenin and amino acids sustains energy without anxiety by inhibiting CD38 to preserve NAD+ levels.

Engineered supplement array combines nicotinamide riboside with mitochondrial, methylation, and sirtuin amalgams to maximize biosynthesis.

Targets NLRP3-inflammasome activation using cannabinoid and receptor modulator compositions to resolve persistent neurologic damage.

Liquid spray formulation moisturizes oral mucosa to resolve dry mouth discomfort during physical strain.

Porous polymers enable transdermal penetration of finasteride, reducing systemic side effects while improving hair growth efficacy.

A herbal-mineral composition inhibits pro-inflammatory cytokine synthesis and release through synergistic botanical and trace element interactions.

Segmented mouthpiece covers prevent saliva transfer to cartridges through friction retention, allowing easy removal without dislodging the insert.

Implantable matrix releases agents into adipose tissue to modify secretion profiles, overcoming limited oral therapy effectiveness.

A diffusional patch applies an oil mixture to reduce edema and hernia mass through osmotic pressure.

Ketone body therapy reverses impaired healing by reducing reactive oxygen species and boosting ATP synthesis in chronic wounds.

Micellar film dosage form encapsulates low solubility cannabinoids in a detergent-based aqueous matrix, enhancing bioavailability while masking bitter taste.

Merging probiotic strains with polyphenols resolves the trade-off between therapeutic effectiveness and harmful side effects in inflammatory treatments.

Amphiphilic alginate nanocomposite gel encapsulates active pharmaceutical ingredients via ionic crosslinking to form a self-sustained porous matrix.

A bowel cleansing composition combines polyethylene glycol with ascorbate ingredients to improve palatability and reduce required dose volume.

Topical resveratrol up-regulates MMP-9 to accelerate collagen remodeling, preventing disorganized scar formation in fresh surgical incisions.

Topical cannabinoids upregulate keratin expression to enhance skin structural integrity.

Combining zebularine with retinoic acid activates silenced genes to overcome age-related decline in regenerative capability.

A cellulose and polyphenol composite forms pH-dependent solubility for enteric film applications.

A resveratrol and vitamin D composition suppresses NLRP3 inflammasome activation to prevent acute respiratory distress syndrome.

Composite cannabinoid mixtures inhibit mast cell degranulation and lipid release, resolving multi-pathway coverage gaps in anti-inflammatory therapies.

Cooling extruded substrates prevents acidic cannabinoid decarboxylation, maintaining therapeutic efficacy while avoiding toxicity in animal feed.

A universal cardioplegic solution combines high and low potassium phases to maintain asystole.

Pre-crosslinked polysaccharide particles prevent aspiration risks during tissue repair.